Association of cystic fibrosis genetic modifiers with congenital bilateral absence of the vas deferens

Fertility and Sterility

Volumn 94, Issue 6, 2010, Pages 2122-2127

  Havasi, Viktoria ^a   Rowe, Steven M ^a   Kolettis, Peter N ^b   Dayangac, Didem ^c   Ahin, Ahmet ^d   Grangeia, Ana ^e   Carvalho, Filipa ^e   Barros, Alberto ^e,f   Sousa, Mario ^e,f   Bassas, Lluis ^g   Casals, Teresa ^h   Sorscher, Eric J ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c HACETTEPE UNIVERSITY   (Turkey)

^d ACIBADEM UNIVERSITY   (Turkey)

^e University of Porto   (Portugal)

^f UNIVERSITY OF PORTO   (Portugal)

^g FUNDACIÓ PUIGVERT   (Spain)

^h BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

CBAVD; CF; CFTR; Congenital bilateral absence of the vas deferens; cystic fibrosis; EDNRA; modifier gene; TGF

Indexed keywords

ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR TYPE A; GENOMIC DNA; TRANSFORMING GROWTH FACTOR BETA1; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ABSENCE OF VAS DEFERENS; ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DNA MODIFICATION; DNA POLYMORPHISM; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PHENOTYPE; PRIORITY JOURNAL; SELF EVALUATION; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY (BIRD); UROGENITAL TRACT MALFORMATION; VAS DEFERENS;

CASE-CONTROL STUDIES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; PENETRANCE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ENDOTHELIN A; RISK FACTORS; SPAIN; TRANSFORMING GROWTH FACTOR BETA1; TURKEY; UROGENITAL ABNORMALITIES; VAS DEFERENS;

EID: 78049277842     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.11.044     Document Type: Article

References (47)

1. P.M. Farrell, B.J. Rosenstein, T.B. White, F.J. Accurso, C. Castellani, and G.R. Cutting Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report J Pediat 153 2008 S4 14
2. B. Kerem, J.M. Rommens, J.A. Buchanan, D. Markiewicz, T.K. Cox, and A. Chakravarti Identification of the cystic fibrosis gene: genetic analysis Science 245 1989 1073 1080 (Pubitemid 19231815)
3. J.R. Riordan, J.M. Rommens, B. Kerem, N. Alon, R. Rozmahel, and Z. Grzelczak Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA Science 245 1989 1066 1073 (Pubitemid 19231814)
4. J.M. Rommens, M.C. Iannuzzi, B. Kerem, M.L. Drumm, G. Melmer, and M. Dean Identification of the cystic fibrosis gene: chromosome walking and jumping Science 245 1989 1059 1065 (Pubitemid 19231813)
5. L.M. Taussig, C.C. Lobeck, P.A. di Sant'Agnese, D.R. Ackerman, and J. Kattwinkel Fertility in males with cystic fibrosis N Engl J Med 287 1972 586 589
6. Cystic Fibrosis Mutation Database The Hospital for Sick Children 1989 Genetics and Genomics Biology Toronto Available at http://www.genet.sickkids.on. ca/cftr/app Accessed on August 25, 2008
7. E. Kerem Atypical CF and CF related diseases Paediat Respiratory Rev 7 Suppl 1 2006 S144 S146
8. Report of a joint WHO/ICF(M)A/ECFTN meeting S, Sweden June 3, 2000. Classification of cystic fibrosis and related disorders J Cyst Fibros 1 2002 5 8
9. C. Castellani, H. Cuppens, M. Macek Jr., J.J. Cassiman, E. Kerem, and P. Durie Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice J Cyst Fibros 7 2008 179 196
10. A. Anguiano, R.D. Oates, J.A. Amos, M. Dean, B. Gerrard, and C. Stewart Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis JAMA 267 1992 1794 1797
11. T. Casals, L. Bassas, S. Egozcue, M.D. Ramos, J. Gimenez, and A. Segura Heterogeneity for mutations in the CFTR gene and clinical correlations in patients with congenital absence of the vas deferens Hum Reprod 15 2000 1476 1483
12. A. Grangeia, R. Sa, F. Carvalho, J. Martin, E. Girodon, and J. Silva Molecular characterization of the cystic fibrosis transmembrane conductance regulator gene in congenital absence of the vas deferens Genet Med 9 2007 163 172
13. I. Ratbi, M. Legendre, F. Niel, J. Martin, J.C. Soufir, and V. Izard Detection of cystic fibrosis transmembrane conductance regulator (CFTR) gene rearrangements enriches the mutation spectrum in congenital bilateral absence of the vas deferens and impacts on genetic counselling Hum Reprod 22 2007 1285 1291
14. M. Taulan, A. Girardet, C. Guittard, J.P. Altieri, C. Templin, and C. Beroud Large genomic rearrangements in the CFTR gene contribute to CBAVD BMC Med Genet 8 2007 22
15. H. Cuppens, and J.J. Cassiman CFTR mutations and polymorphisms in male infertility Intern J Androl 27 2004 251 256
16. L.B. Baskin, F.H. Wians Jr., and F. Elder Preconception and prenatal screening for cystic fibrosis MLO: medical laboratory observer 34 2002 8 12 quiz 4, 6
17. R. Radpour, E. Taherzadeh-Fard, H. Gourabi, S. Aslani, A. Vosough Dizaj, and A. Aslani Novel cause of hereditary obstructive azoospermia: a T2 allele in the CFTR gene Reprod Biomed Online 18 2009 327 332
18. A. Disset, C. Michot, A. Harris, E. Buratti, M. Claustres, and S. Tuffery-Giraud A T3 allele in the CFTR gene exacerbates exon 9 skipping in vas deferens and epididymal cell lines and is associated with Congenital Bilateral Absence of Vas Deferens (CBAVD) Hum Mutation 25 2005 72 81
19. V. Mak, K.A. Jarvi, J. Zielenski, P. Durie, and L.C. Tsui Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens Hum Mol Genet 6 1997 2099 2107 (Pubitemid 27477952)
20. S. Kiesewetter, M. Macek Jr., C. Davis, S.M. Curristin, C.S. Chu, and C. Graham A mutation in CFTR produces different phenotypes depending on chromosomal background Nature Genet 5 1993 274 278
21. N. Rave-Harel, E. Kerem, M. Nissim-Rafinia, I. Madjar, R. Goshen, and A. Augarten The molecular basis of partial penetrance of splicing mutations in cystic fibrosis Am J Hum Genet 60 1997 87 94
22. M. Claustres Molecular pathology of the CFTR locus in male infertility Reprod Biomed Online 10 2005 14 41
23. M.L. Drumm, M.W. Konstan, M.D. Schluchter, A. Handler, R. Pace, and F. Zou Genetic modifiers of lung disease in cystic fibrosis N Engl J Med 353 2005 1443 1453
24. Y. Yamada, A. Miyauchi, J. Goto, Y. Takagi, H. Okuizumi, and M. Kanematsu Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women J Bone Miner Res 13 1998 1569 1576
25. M. Suthanthiran, B. Li, J.O. Song, R. Ding, V.K. Sharma, and J.E. Schwartz Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage Proc Natl Acad Sci U S A 97 2000 3479 3484
26. A.M. Dunning, P.D. Ellis, S. McBride, H.L. Kirschenlohr, C.S. Healey, and P.R. Kemp A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer Cancer Res 63 2003 2610 2615
27. M.R. Awad, A. El-Gamel, P. Hasleton, D.M. Turner, P.J. Sinnott, and I.V. Hutchinson Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation Transplantation 66 1998 1014 1020
28. P.D. Arkwright, S. Laurie, M. Super, V. Pravica, M.J. Schwarz, and A.K. Webb TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis Thorax 55 2000 459 462
29. Darrah R, Thapar V, Smith P, Goddard K, Londono D, Dunn J, et al. Variants in the endothelin receptor A gene associate with increased expression levels, increased cell proliferation and more severe pulmonary disease in CF females In: North American Cystic Fibrosis Conference. Anaheim, California, USA. Pediatric Pulmonology 2007;42:73-428.
30. McKone EF, O'Connor CM, Rodgers CE, Genatossio A, McNamara S, Gibson RL, et al. TagSNP evaluation of the endothelin pathway demonstrates genetic association between EDNRA and CF lung disease severity. In: North American Cystic Fibrosis Conference. Anaheim, California, USA. Pediatric Pulmonology 2007;42:73-428.
31. D.A. Lawrence Transforming growth factor-beta: a general review Europ Cytokine Network 7 1996 363 374
32. A. Goraca New views on the role of endothelin (minireview) Endocrine Reg 36 2002 161 167
33. M. Yamaguchi, A. Niimi, H. Matsumoto, T. Ueda, M. Takemura, and H. Matsuoka Sputum levels of transforming growth factor-beta1 in asthma: relation to clinical and computed tomography findings J Investig Allergol Clin Immunol 18 2008 202 206
34. D.W. Hay Putative mediator role of endothelin-1 in asthma and other lung diseases Clin Exper Pharmacol Physiol 26 1999 168 171
35. B. Corrin, D. Butcher, B.J. McAnulty, R.M. Dubois, C.M. Black, and G.J. Laurent Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders Histopathology 24 1994 145 150
36. G.C. Blobe, W.P. Schiemann, and H.F. Lodish Role of transforming growth factor beta in human disease N Engl J Med 342 2000 1350 1358
37. B. Hocher, A. Schwarz, K.A. Fagan, C. Thone-Reineke, K. El-Hag, and H. Kusserow Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice Am J Respir Cell Mol Biol 23 2000 19 26
38. R. Jain, P.W. Shaul, Z. Borok, and B.C. Willis Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1 Am J Respir Cell Mol Biol 37 2007 38 47
39. Technelysium Pty Ltd Chromas Lite Freeware. Tewantin, Australia, 2005. Available at: http://www.technelysium.com.au/chromas
40. J.D. Thompson, D.G. Higgins, and T.J. Gibson CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice Nucl Acids Res 22 1994 4673 4680
41. L.P. Sanford, I. Ormsby, A.C. Gittenberger-de Groot, H. Sariola, R. Friedman, and G.P. Boivin TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes Development 124 1997 2659 2670
42. K.L. Stenvers, M.L. Tursky, K.W. Harder, N. Kountouri, S. Amatayakul-Chantler, and D. Grail Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos Mol Cell Biol 23 2003 4371 4385
43. S.E. Hannema, C.G. Print, D.S. Charnock-Jones, N. Coleman, and I.A. Hughes Changes in gene expression during Wolffian duct development Hormone Res 65 2006 200 209
44. L.B. Ruest, X. Xiang, K.C. Lim, G. Levi, and D.E. Clouthier Endothelin-A receptor-dependent and -independent signaling pathways in establishing mandibular identity Development 131 2004 4413 4423
45. P. Pla, and L. Larue Involvement of endothelin receptors in normal and pathological development of neural crest cells Intern J Dev Biol 47 2003 315 325
46. S.W. Moore, and M.G. Zaahl Association of endothelin-beta receptor (EDNRB) gene variants in anorectal malformations J Pediat Surg 42 2007 1266 1270
47. L. Stanchina, V. Baral, F. Robert, V. Pingault, N. Lemort, and V. Pachnis Interactions between Sox10, Edn3 and Ednrb during enteric nervous system and melanocyte development Dev Biol 295 2006 232 249